Search
-
Ipsos Update - November 2024
Mental Health, AI, Infrastructure … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
GLP–1s: A Healthcare Revolution?
One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
-
Conversations with AI Part VI: AI-powered moderator bots: Enhancing empathy or eroding connection?
In the sixth white paper in our Ipsos Views Conversations with AI series, we explore the role of a Moderator Bot powered by generative AI within qualitative research.
-
Ipsos Update - October 2024
Trends, News, Ageing … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Predicting Opportunity in Emerging Therapies
The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.
-
Introducing Ipsos’ newly updated CX Maturity Assessment and CX Roadmap – now including CX Maturity Benchmark
How mature is your organisation’s Customer Experience? Want to know how your organisation measures up?
And what you need to do to get where you need to be? -
Ipsos Update – September 2024
Data, Healthcare, Education … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Rare Diseases: A Diagnostic Odyssey
Unravelling the Complexities of Rare Diseases: A Market Research Perspective